Showing results (1-10 of 467) with videos related to
Sort By:
Pageof 47
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
PD-L1 IHC in NSCLC with a global and methodological perspectiveErik Thunnissen, Adrianus J de Langen, Egbert F SmitTherapeutic Advances in Medical Oncology|February 17, 2017
Therapeutic approach to treating patients with BRAF-mutant lung cancer: latest evidence and clinical implicationsAdrianus J de Langen, Egbert F SmitJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2018
Afatinib and Cetuximab in Four Patients With EGFR Exon 20 Insertion-Positive Advanced NSCLCBianca van Veggel, Adrianus J de Langen, Sayed M S Hashemi, et al.European Respiratory Review : an Official Journal of the European Respiratory Society|June 30, 2017
Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens: Number 2 in the Series "Pathology for the clinician" Edited by Peter Dorfmüller and Alberto CavazzaLukas Bubendorf, Sylvie Lantuejoul, Adrianus J de Langen, et al.British Journal of Cancer|August 1, 2018
Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatmentAdrianus J de Langen, M Jebbink, Sayed M S Hashemi, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2018
A Population-Based Study of Outcomes in Surgically Resected T3N0 Non-Small Cell Lung Cancer in The Netherlands, Defined Using TNM-7 and TNM-8; Justification of Changes and an Argument to Incorporate Histology in the Staging AlgorithmHans Blaauwgeers, Ronald Damhuis, Birgit I Lissenberg-Witte, et al.Nederlands Tijdschrift Voor Geneeskunde|March 23, 2011
[EGFR-mutation in non-small cell lung carcinoma. Treatment with tyrosine kinase inhibitors possible]Erik Thunnissen, Egbert F Smit, Petra M Nederlof, et al.Oncoimmunology|May 1, 2023
Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodesFrank J Borm, Jasper Smit, Joyce Bakker, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 18, 2008
Reproducibility of tumor perfusion measurements using 15O-labeled water and PETAdrianus J de Langen, Mark Lubberink, Ronald Boellaard, et al.ERJ Open Research|June 1, 2017
High PD-1 expression on regulatory and effector T-cells in lung cancer draining lymph nodesRieneke van de Ven, Anna-Larissa N Niemeijer, Anita G M Stam, et al.Pageof 47